The US Food and Drug Administration has approved a messenger RNA-based vaccine against respiratory syncytial virus (RSV) for people aged 60 and older.
Alicia Lasek is a journalist who writes for McKnight's Long-Term Care News, with her work also appearing in McKnight's Senior Living. She covers a range of topics related to long-term care, including healthcare policies, medical advancements, and the impact of various factors on the well-being of older adults.